Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

29452 ARTÍCULOS , VIENDO DEL 2341 AL 2355

p38α Mitogen-Activated Protein Kinase-An Emerging Drug Target for the Treatment of Alzheimer's Disease

Detka J, Płachtij N, Strzelec M, Manik A, Sałat K.

Molecules. 2024 Sep 13;29(18):4354. doi: 10.3390/molecules29184354.

[Type 2 diabetes and Alzheimer's disease - are there common microbial roots?]

Fekete C, Schandl L, Tomasics G, Egey A, Kis J, Winkler G.

Orv Hetil. 2024 Sep 29;165(39):1522-1528. doi: 10.1556/650.2024.33128. Print 2024 Sep 29.

Therapeutic approaches to microglial dysfunction in Alzheimer's disease: Enhancing phagocytosis and metabolic regulation

Almalki WH, Almujri SS.

Pathol Res Pract. 2024 Nov;263:155614. doi: 10.1016/j.prp.2024.155614. Epub 2024 Sep 25.

Mechanisms Underlying Obesity-induced Aβ Accumulation in Alzheimer's Disease: A Qualitative Review

Wen W, Huang SM, Zhang B.

J Integr Neurosci. 2024 Sep 5;23(9):163. doi: 10.31083/j.jin2309163.

Alzheimer's Disease and Effects of ABCA7 Polymorphisms: A Review

Gialama V, Siokas V, Liampas I, Tsouris Z, Stamati P, Aslanidou P, Provatas A, Tsimourtou V, Xiromerisiou G, Bogdanos DP, Dardiotis E.

J Integr Neurosci. 2024 Sep 6;23(9):164. doi: 10.31083/j.jin2309164.

Therapeutic Efficacy of Extracellular Vesicles Derived from Stem Cell for Alzheimer's Disease: A Meta-Analysis Study

Deng H, Zhao J, Li J, Chen C, Hu Z, Wu X, Ge L.

Front Biosci (Landmark Ed). 2024 Sep 25;29(9):340. doi: 10.31083/j.fbl2909340.

Naringin and Naringenin: Potential Multi-Target Agents for Alzheimer's Disease

Lu J, Chen J, Li SY, Pan GJ, Ou Y, Yuan LF, Jiang JP, Zeng LH, Zhao J.

Curr Med Sci. 2024 Oct;44(5):867-882. doi: 10.1007/s11596-024-2921-z. Epub 2024 Sep 30.

Progress in the Treatment of Alzheimer's Disease Is Needed - Position Statement of European Alzheimer's Disease Consortium (EADC) Investigators

Jessen F, Kramberger MG, Angioni D, Aarsland D, Balasa M, Bennys K, Boada M, Boban M, Chincarini A, Exalto L, Felbecker A, Fliessbach K, Frisoni GB, Garza-Martínez AJ, Grimmer T, Hanseeuw B, Hort J, Ivanoiu A, Klöppel S, Krajcovicova L, McGuinness B, Mecocci P, de Mendonca A, Nous A, Ousset PJ, Paquet C, Perneczky R, Peters O, Tabuas-Pereira M, Piazza F, Plantone D, Riverol M, Ruiz A, Sacco G, Santana I, Scarmeas N, Solje E, Stefanova E, Sutovsky S, van der Flier W, Welsh T, Wimo A, Winblad B, Frölich L, Engelborghs S.

J Prev Alzheimers Dis. 2024;11(5):1212-1218. doi: 10.14283/jpad.2024.153.

Semorinemab Pharmacokinetics and The Effect on Plasma Total Tau Pharmacodynamics in Clinical Studies

Ramakrishnan V, Bender B, Langenhorst J, Magnusson MO, Dolton M, Shim J, Fuji RN, Monteiro C, Teng E, Kassir N, Jin J.

J Prev Alzheimers Dis. 2024;11(5):1241-1250. doi: 10.14283/jpad.2024.146.

A review on synthetic inhibitors of dual-specific tyrosine phosphorylation-regulated kinase 1A (DYRK1A) for the treatment of Alzheimer's disease (AD)

Gehlot P, Pathak R, Kumar S, Choudhary NK, Vyas VK.

Bioorg Med Chem. 2024 Nov 1;113:117925. doi: 10.1016/j.bmc.2024.117925. Epub 2024 Sep 14.

Inflammatory proteins associated with Alzheimer's disease reduced by a GLP1 receptor agonist: a post hoc analysis of the EXSCEL randomized placebo controlled trial

Koychev I, Reid G, Nguyen M, Mentz RJ, Joyce D, Shah SH, Holman RR.

Alzheimers Res Ther. 2024 Oct 2;16(1):212. doi: 10.1186/s13195-024-01573-x.

Gut microbiota and Alzheimer's disease: Exploring natural product intervention and the Gut-Brain axis for therapeutic strategies

Pasupalak JK, Rajput P, Gupta GL.

Eur J Pharmacol. 2024 Dec 5;984:177022. doi: 10.1016/j.ejphar.2024.177022. Epub 2024 Oct 1.

Mitochondrial dysfunction gene expression, DNA methylation, and inflammatory cytokines interaction activate Alzheimer's disease: a multi-omics Mendelian randomization study

Zhang XX, Wei M, Wang HR, Hu YZ, Sun HM, Jia JJ.

J Transl Med. 2024 Oct 3;22(1):893. doi: 10.1186/s12967-024-05680-z.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias